The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine

Statistical Power Analysis for the Behavioral Sciences

1989 • 83,906 citations

Statistical power analysis for the behavioral sciences

1990 • 65,781 citations

The central role of the propensity score in observational studies for causal effects

1983 • 26,882 citations

Wechsler Adult Intelligence Scale-III

2001 • 3,761 citations

What are the functional consequences of neurocognitive deficits in schizophrenia?

1996 • 3,505 citations

Wisconsin Card Sorting Test Manual – Revised and Expanded

1981 • 2,973 citations

Neurocognitive Deficits and Functional Outcome in Schizophrenia: Are We Measuring the "Right Stuff"?

2000 • 2,955 citations

Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.

1998 • 2,422 citations

Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.

1998 • 2,270 citations

Efficient Estimation of Average Treatment Effects Using the Estimated Propensity Score

2003 • 2,234 citations

Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS

2004 • 1,383 citations

Move Over ANOVA

2004 • 1,373 citations

Identification of separable cognitive factors in schizophrenia

2004 • 1,248 citations

Information Processing and Attentional Functioning in the Developmental Course of Schizophrenic Disorders

1984 • 1,159 citations

Neuropsychological Function in Schizophrenia

1991 • 1,158 citations

Memory Impairment in Schizophrenia: A Meta-Analysis

1999 • 1,092 citations

The Effects of Clozapine, Risperidone, and Olanzapine on Cognitive Function in Schizophrenia

1999 • 1,012 citations

Predicting premorbid IQ: A revision of the national adult reading test

1989 • 986 citations

Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology

2003 • 918 citations

Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors

2002 • 896 citations

Olanzapine versus Placebo and Haloperidol

1996 • 788 citations

The Effects of Atypical Antipsychotic Drugs on Neurocognitive Impairment in Schizophrenia: A Review and Meta-analysis

1999 • 698 citations

The continuous performance test, identical pairs version (CPT-IP): I. new findings about sustained attention in normal families

1988 • 658 citations

Studies of Cognitive Change in Patients With Schizophrenia Following Novel Antipsychotic Treatment

2001 • 622 citations

Aripiprazole, an Antipsychotic With a Novel Mechanism of Action, and Risperidone vs Placebo in Patients With Schizophrenia and Schizoaffective Disorder

2003 • 591 citations

A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia

2005 • 586 citations

Neurocognitive Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol in Patients With Chronic Schizophrenia or Schizoaffective Disorder

2002 • 536 citations

Further Evidence for Dementia of the Prefrontal Type in Schizophrenia?

1987 • 524 citations

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

2002 • 506 citations

Neuropsychological Change in Early Phase Schizophrenia During 12 Months of Treatment With Olanzapine, Risperidone, or Haloperidol

2000 • 478 citations

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

2003 • 472 citations

Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

1997 • 406 citations

Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine

1993 • 403 citations

Cognitive deficits as treatment targets in schizophrenia

2004 • 367 citations

The distinctiveness of stimuli.

1960 • 273 citations

7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.

1995 • 268 citations

A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.

2004 • 238 citations

Directional statistical decisions.

1960 • 201 citations

Effects of clozapine on cognitive function in schizophrenia.

1994 • 200 citations

Positive and Negative Schizophrenic Symptoms, Attention, and Information Processing

1985 • 178 citations

The Effects of Clozapine on Symptom Reduction, Neurocognitive Function, and Clinical Management in Treatment-Refractory State Hospital Schizophrenic Inpatients

1996 • 135 citations

Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study

1997 • 122 citations

Risperidone versus Haloperidol on Secondary Memory: Can Newer Medications Aid Learning?

1999 • 95 citations

Brain region effects of clozapine on amino acid and monoamine transmission.

1994 • 80 citations

Neuropsychological Normalization With Long-Term Atypical Antipsychotic Treatment: Results of a Six-Month Randomized, Double-Blind Comparison of Ziprasidone vs. Olanzapine

2006 • 47 citations

A Canadian Multicenter Trial Assessing Memory and Executive Functions in Patients With Schizophrenia Spectrum Disorders Treated With Olanzapine

2003 • 31 citations

Neuropsychological Normalization With Long-Term Atypical Antipsychotic Treatment: Results of a Six-Month Randomized, Double-Blind Comparison of Ziprasidone vs. Olanzapine

2006 • 11 citations

Deleted Work

1955 • 0 citations